Corona Remedies IPO — Listing Performance
Corona Remedies IPO facts & figures
| Issue category | Mainboard |
|---|---|
| Issue open date | 8 Dec 2025 |
| Listing date | 15 Dec 2025 |
| Issue price | ₹1,062 |
| Listing-day close | ₹1,438.40 (35.44%) |
| Recent market price | ₹2,149.60 (102.41% vs issue) |
| 52-week range | ₹1,347.70 – ₹2,165.80 |
| Identifiers | NSE: CORONA · ISIN: INE02ZQ01018 |
How the listing went
Corona Remedies had a strong market debut, ending listing day 35.44% over the issue price.
Corona Remedies against every other debut on record
- Rank in 2025: 29 of 215 NSE debuts, on a 35.44% first-day close.
- 90th percentile of 99 mainboard debuts in 2025 (median 5.11%).
- 4th of 24 debuts in December 2025.
- Opened 38.42% above issue, then gave up 2.98 points to the close.
- Day-one range ₹1,413 to ₹1,497.80: a 7.98% swing on the issue price.
- Last close ₹2,149.60 (30 Oct 2026): 102.41% above issue, against 35.44% on day one.
- 98% up its 52-week range of ₹1,347.70 to ₹2,165.80.
- Priced at the top of the ₹1,008 to ₹1,062 band.
- Listed 5 calendar days after close.
- All 547 mainboard debuts on record: median 11.6%, 72% closed above issue.
Computed over 1161 verified NSE debuts to 28 Oct 2026 · sources